Emerald Health Therapeutics Reports Fourth Quarter and Fiscal 2018 Financial Results; Highlights Sales Growth in Q1 2019

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the fourth quarter and year ended December 31, 2018. Highlights Emerald’s Q4…

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the fourth quarter and year ended December 31, 2018. Highlights Emerald’s Q4 sales of $1.1 million was more than triple the prior quarter and year-over year; Q1 2019 sales were $2.6 million. Quebec-based Verdélite subsidiary expected to be in full production in […]

The post Emerald Health Therapeutics Reports Fourth Quarter and Fiscal 2018 Financial Results; Highlights Sales Growth in Q1 2019 appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *